111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Analyze DCF forecasts for the company and compare them with competitors.
26.03B
No previous data to compare.
No Data
No DCF data available for this metric in the selected year.
4.14B
No previous data to compare.
15.89%
No previous data to compare.
2.28B
No previous data to compare.
8.76%
No previous data to compare.
1.86B
No previous data to compare.
9.18B
No previous data to compare.
35.26%
No previous data to compare.
3.31B
No previous data to compare.
12.71%
No previous data to compare.
2.85B
No previous data to compare.
10.95%
No previous data to compare.
1.70B
No previous data to compare.
6.53%
No previous data to compare.
-1.26B
No previous data to compare.
-4.83%
No previous data to compare.
9.64%
No previous data to compare.
10.90%
No previous data to compare.
4.40%
No previous data to compare.
1.38
No previous data to compare.
729.20M
No previous data to compare.
13.52B
No previous data to compare.
68.33B
No previous data to compare.
81.85B
No previous data to compare.
16.51%
No previous data to compare.
83.49%
No previous data to compare.
1.70B
No previous data to compare.
-2.16B
No previous data to compare.
2.00%
No previous data to compare.
56.34B
No previous data to compare.
50.73B
No previous data to compare.
6.94B
No previous data to compare.
43.79B
No previous data to compare.
60.05
No previous data to compare.
Analyze analyst forecasts for the company and compare them with competitors.
27.27B
The estimated revenue has decreased from the previous period.
4.49B
The estimated EBITDA has decreased from the previous period.
2.13
The estimated EPS has decreased from the previous period.
1.56B
The estimated net income has decreased from the previous period.
2.98B
The estimated EBIT has decreased from the previous period.
6.11B
The estimated SG&A expenses have decreased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$114.00
Analysts expect the stock price to decrease by 0.24%.
Buy
Positive consensus among analysts.
